| Advanced and Metastatic Breast Cancer |
1 |
1 |
| Breast Cancer |
0 |
0.99 |
| HER2-Negative Breast Cancer |
0 |
0.78 |
| Biologic Therapy |
0 |
0.68 |
| Cancer |
0 |
0.6 |
| Metastasis |
0 |
0.55 |
| Breast |
0 |
0.54 |
| Genomic Medicine |
0 |
0.53 |
| Targeted Cancer Therapy |
0 |
0.49 |
| Endocrine Therapy |
0 |
0.42 |
| Toxicology |
0 |
0.38 |
| Biomedical Technology |
0 |
0.24 |
| Healthcare and Medical Technology |
0 |
0.22 |
| Genetics |
0 |
0.18 |
| Genetic Testing |
0 |
0.17 |
| Receptors |
0 |
0.12 |
| A-Scan Biometry |
0 |
0.06 |
| Aromatase Inhibitors |
0 |
0.06 |
| Biomarker |
0 |
0.06 |
| Care and Maintenance of Vision |
0 |
0.06 |
| Cataract |
0 |
0.06 |
| Chemotherapy |
0 |
0.06 |
| New York |
0 |
0.06 |
| Scan |
0 |
0.06 |
| Tumor |
0 |
0.06 |
| Wisconsin |
0 |
0.06 |